Skip to main content
. Author manuscript; available in PMC: 2008 Sep 1.
Published in final edited form as: Exp Neurol. 2007 Jun 19;207(1):118–127. doi: 10.1016/j.expneurol.2007.06.003

Figure 5. [11C]DAA1106 is retained at greater levels at the site of the lesion compared to [11C](R)-PK11195 in rats with TBI.

Figure 5

Rats with CCI were injected with either [11C]DAA1106 or [11C](R)-PK11195 (1–2mCi) intravenously. A 30-minute uptake period was allowed after radiotracer injection, following which animals were sacrificed and brain tissue was processed for ex-vivo autoradiography. Uptake of [11C]DAA1106 at the site of lesion (A) is greater than [11C](R)-PK11195 uptake (B).

HHS Vulnerability Disclosure